MétaCan
Menu
Back to cohort
Record W4392980187 · doi:10.1016/j.kint.2023.10.016

Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns

2024· article· en· W4392980187 on OpenAlexaff
Adeera Levin, Sofia B. Ahmed, Juan Jesús Carrero, Bethany J. Foster, Anna Francis, Rasheeda K. Hall, William G. Herrington, G. Hill, Lesley A. Inker, Rümeyza Kazancıoğlu, Edmund J. Lamb, Peter Lin, Magdalena Madero, Natasha J. McIntyre, Kelly Morrow, Glenda V. Roberts, Dharshana Sabanayagam, Elke Schäeffner, Michael Shlipak, Rukshana Shroff, Navdeep Tangri, Teerawat Thanachayanont, Ifeoma Ulasi, Germaine Wong, Chih‐Wei Yang, Luxia Zhang, Karen A. Robinson, Lisa M Wilson, Renée F Wilson, Bertram L. Kasiske, Michael Cheung, Amy Earley, Paul E. Stevens

Bibliographic record

VenueKidney International · 2024
Typearticle
Languageen
FieldMedicine
TopicChronic Kidney Disease and Diabetes
Canadian institutionsLondon Health Sciences CentreWestern UniversityUniversity of AlbertaVictoria HospitalMcGill UniversityUniversity of British ColumbiaUniversity of ManitobaCanadian Heart Research CentreProvidence Health Care
Fundersnot available
KeywordsGuidelineMedicineKidney diseaseIntensive care medicineSystematic reviewHealth careGrading (engineering)MEDLINEBest practiceExecutive summaryPathologyInternal medicineBusinessPolitical science

Abstract

fetched live from OpenAlex

The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) updates the KDIGO 2012 guideline and has been developed with patient partners, clinicians, and researchers around the world, using robust methodology. This update, based on a substantially broader base of evidence than has previously been available, reflects an exciting time in nephrology. New therapies and strategies have been tested in large and diverse populations that help to inform care; however, this guideline is not intended for people receiving dialysis nor those who have a kidney transplant. The document is sensitive to international considerations, CKD across the lifespan, and discusses special considerations in implementation. The scope includes chapters dedicated to the evaluation and risk assessment of people with CKD, management to delay CKD progression and its complications, medication management and drug stewardship in CKD, and optimal models of CKD care. Treatment approaches and actionable guideline recommendations are based on systematic reviews of relevant studies and appraisal of the quality of the evidence and the strength of recommendations which followed the "Grading of Recommendations Assessment, Development, and Evaluation" (GRADE) approach. The limitations of the evidence are discussed. The guideline also provides practice points, which serve to direct clinical care or activities for which a systematic review was not conducted, and it includes useful infographics and describes an important research agenda for the future. It targets a broad audience of people with CKD and their healthcare, while being mindful of implications for policy and payment.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.015
metaresearch head score (Gemma)0.093
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.056
Threshold uncertainty score0.186

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0150.093
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0030.003
Bibliometrics0.0060.008
Science and technology studies0.0010.001
Scholarly communication0.0060.004
Open science0.0030.002
Research integrity0.0050.007
Insufficient payload (model declined to judge)0.0560.055

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.031
GPT teacher head0.391
Teacher spread0.360 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations319
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueKidney InternationalSame topicChronic Kidney Disease and DiabetesFrench-language works237,207